Safety and Efficacy of Infant Formulas Supplemented With Pre- and Probiotic(s)

NACompletedINTERVENTIONAL
Enrollment

318

Participants

Timeline

Start Date

September 2, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

April 4, 2024

Conditions
Healthy Infants
Interventions
OTHER

Experimental formulas (EF)

First age formula administered orally ad libitum until 6 months of age, switch to second age formula until 12 months and finally to growing-up milk from 12 to 15 months

OTHER

Control formulas (CF)

First age formula administered orally ad libitum until 6 months of age, switch to second age formula until 12 months and finally to growing-up milk from 12 to 15 months

OTHER

Breast feeding (BF)

Exclusive breast feeding up to 4 months

Trial Locations (18)

1090

Universitair Ziekenhuis Brussel, Brussels

3500

Kinderartsen Huis, Hasselt

4000

CHC-Groupe santé, Clinique MontLégia, Liège

CHU de Liège - CHR de la Citadelle, Liège

8000

AZ Sint-Jan Brugge-Oostende AV, Bruges

13589

Evangelisches Waldkrankenhaus Spandau, Spandau

14004

Reina Sofía University Hospital, Córdoba

18059

Klinikum Südstadt Rostock, Rostock

37044

Hôpital Bretonneau, CHRU de Tours, Tours

41014

Instituto Hispalense de Pediatría, Unidad de Investigación, Seville

69004

Hôpital de la Croix Rousse, Lyon

69677

Hôpital Femme Mère Enfant, Bron

76031

CHU Charles Nicolle, Rouen

80054

CHU Amiens-Picardie, Amiens

Unknown

CHU de Nantes, Nantes

Hospital Vithas Castellón, Castellon

Hospital Vithas Valencia, Valencia

Quironsalud Valencia Hospital, Valencia

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT04962594 - Safety and Efficacy of Infant Formulas Supplemented With Pre- and Probiotic(s) | Biotech Hunter | Biotech Hunter